Avastin Photos on Townhall

  •  -
    Posted: 4/5/2012 2:45:46 AM EST
    This photo provided by Office of Public Affairs, FDA shows a counterfeit version of the best-selling cancer drug Avastin. The Food and Drug Administration is warning doctors that a second counterfeit version of the best-selling cancer drug Avastin has been found in the U.S., packaged as the Turkish brand of the medication. The FDA said late Tuesday, April 3, 2012, that the counterfeits do not contain the active ingredient in Avastin, which is used to treat cancers of the colon, lung, kidney and brain. The vials are packaged as Altuzan, the Turkish version of Avastin that is not approved for use in the U.S. The agency says any packages or vials labeled with the lot number B6021 should be considered counterfeit. (AP Photo/Office of Public Affairs, FDA )
  •  -
    Posted: 2/17/2012 4:50:53 AM EST
    FILE - This undated file photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. A long delayed effort to create an electronic system to weed out counterfeit drugs is likely to get a renewed push after this week's discovery that a fake version of the cancer drug Avastin was distributed to doctors in three states. (AP Photo/Genetech)
  •  -
    Posted: 2/15/2012 6:25:45 PM EST
    This undated photo provided by Genetech shows a counterfeit vial of the cancer drug Avastin. The maker of the best-selling cancer drug Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do not contain the key ingredient in Avastin, which is used to treat cancers of the colon, lung, kidney and brain. (AP Photo/Genetech)
  •  -
    Posted: 2/15/2012 6:25:45 PM EST
    This undated photo provided by Genentech shows a counterfeit package for the cancer drug Avastin. The maker of Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do not contain the key ingredient in Avastin, which is used to treat cancers of the colon, lung, kidney and brain. (AP Photo/Genentech)
  •  -
    Posted: 2/15/2012 6:25:45 PM EST
    This product image provided by Genentech shows a vial and package for the cancer drug Avastin. The maker of Avastin is warning doctors and patients about counterfeit vials of the product distributed in the U.S. Roche's Genentech unit says the fake products do not contain the key ingredient in Avastin, which is used to treat cancers of the colon, lung, kidney and brain. (AP Photo/Genentech)
  •  -
    Posted: 1/25/2012 5:45:47 PM EST
    This undated photo provided by Genentech Inc. on Jan. 31, 2011 shows a vial of the drug Avastin. Surprising results from two new studies may reopen the debate about the value of Avastin for breast cancer. The drug helped make tumors disappear when given with chemotherapy before surgery to certain women with early-stage disease, doctors found. The FDA recently revoked Avastin's approval for advanced breast cancer, but the studies suggest it might help others whose cancer has not widely spread. (AP Photo/Genentech Inc., File)
  •  - Roche CEO Schwan addresses media as he attends the company's annual news conference in Basel

    Roche CEO Schwan addresses media as he attends the company's annual news conference in Basel

    Posted: 2/2/2011 5:27:25 AM EST
    Swiss pharmaceutical company Roche CEO Severin Schwan addresses media as he attends the company's annual news conference in Basel February 2, 2011. Swiss drugmaker Roche struck a cautious note on 2011, as the sector grapples with U.S. healthcare reforms and a push in Europe for lower drug prices, after growth of its top-seller Avastin slowed sharply in 2010. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH)